Key Nutrition Logo

Clinical Nutrition Services

London

020 7183 8484

info@key-nutrition.com

Our role is to educate, support and inspire you

to make positive changes

to your diet, lifestyle

and health


Be healthy!

Sign up to our newsletter and start optimising your health today.


Join our mailing list

Nutri PeopleBANT member

Psoriasis


Back to Skin Health

Back to Conditions


Psoriasis is a hypoproliferative skin disorder where the rate of cellular division is 1000 times greater than in normal skin.  It is a distressing condition typically characterised by red patches covered with fine silvery scales. These can be found anywhere on the body although most common are on the scalp, back side of wrists, elbows, knees, buttocks, ankles and sites of repeated trauma. Nails can also be affected. 


The rate at which skin cells divide is controlled by a balance between two internal compounds -- cAMP and cGMP.  Increased levels of cAMP are associated with reduced cell proliferation.  Conversely, increased levels are of cGMP are associated with increased cell proliferation.  In the skin of psoriasis sufferers higher levels of cGMP and lower levels of cAMP have been measured.  This results in excessive proliferation1.  There also often appears to be abnormal immune system stimulation whereby unidentified allergens can trigger an immune response resulting in the proliferation of skin cells.



Causes

A number of factors that may to contribute towards psoriasis:



Nutritional factors to consider

Although psoriasis can have a significant genetic component nutritional intervention can help rebalance the cAMP/cGMP ratio and decrease immune activators present in the blood.



Possible laboratory tests



1 Voorhees J, Duell E. Imbalanced cyclic AMP-cyclic GMP levels in psoriasis. Adv Cyc Nucleotide Res 1975;5:755-757.
2 Proctor M., Wilkenson D., Orenberg E. et al. Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis. Arch Dermatol 1979; 115:945-949.
3 Ojetti V, Aguilar Sanchez J, Guerriero C, et al.. High prevalence of celiac disease in psoriasis. Am J Gastroenterol 2003;98:2574-2575
4 Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn's disease. J Am Acad Dermatol 2003;48:805-821.
5 Gyurcsovics K, Bertok L. Pathophysiology of psoriasis: coping endotoxins with bile acid therapy. Pathophysiology 2003;10:57-61.
6 Weber G, Galle K. [The liver, a therapeutic target in dermatoses.] Med Welt 1983;34:108-111.
7 Pietrzak A, Lecewicz-Torun B, Kadziela-Wypyska G. Changes in the digestive system in patients suffering from psoriasis. Ann Univ Mariae Curie Sklodowska [Med] 1998;53:187-194 8 Douglas JM. Psoriasis and diet. Calif Med 1980;133:450
9 Zlatkov NB, Ticholov JJ, Dourmishev AL. Free fatty acids in the blood serum of psoriatics. Acta Derm Venereol 1984;64:22-25
10 Donadini A., Dazzaglia A., Desirello G. Plasma levels of Zn, Cu and Ni in healthy controls and in psoriatic patients. Possible correlations with vitamins. Acta Vitamin Enzymol 1980; 1:9-16
11 Majewski S., Janik P., Langer A., et al. Decreased levels of vitamin A in serum of patients with psoriasis. Arch Dermatol Res. 1989;280:499-50
12 Rakhmatov A. Characteristics of basal insulinemia in patients with psoriasis. Vestn Dermatol Venerol. 1989; 10:44-7.
13 Seville RH. Psoriasis and stress. Br J Dermatol 1977;97:297-302
14 Monk B.E., Neill S.M. Alcohol consumption and psoriasis. Dermatologica 1986; 173:57-60.